Skip to main content

United States Dasatinib Market 2017 (20 mg Tablets, 50 mg Tablets, 70 mg Tablets, 80 mg Tablets, 100 mg Tablets and 140 mg Tablets) Industry Growth, Analysis, Size and Share to 2022

Press Release   •   Aug 11, 2017 03:25 EDT

In this report, the United States Dasatinib Market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Click Here To Get Request Sample: http://globalqyresearch.com/download-sample/254520 

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Dasatinib in these regions, from 2012 to 2022 (forecast).

United States Dasatinib market competition by top manufacturers/players, with Dasatinib sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Bristol-Myers Squibb
Otsuka Pharmaceutical
CTTQ PHARMA
APOTEX INC

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

20 mg Tablets
50 mg Tablets
70 mg Tablets
80 mg Tablets
100 mg Tablets
140 mg Tablets

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Dasatinib for each application, including
Chronic Myelogenous Leukemia (CML)
Philadelphia Chromosome-positive?Acute Lymphoblastic Leukemia(Ph+ ALL)
Advanced Prostate Cancer

Ask Query Here:Jay@globalqyresearch.com or Sales@globalqyresearch.com

Table of Contents

United States Dasatinib Market Report 2017
1 Dasatinib Overview
1.1 Product Overview and Scope of Dasatinib
1.2 Classification of Dasatinib by Product Category
1.2.1 United States Dasatinib Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Dasatinib Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 20 mg Tablets
1.2.4 50 mg Tablets
1.2.5 70 mg Tablets
1.2.6 80 mg Tablets
1.2.7 100 mg Tablets
1.2.8 140 mg Tablets
1.3 United States Dasatinib Market by Application/End Users
1.3.1 United States Dasatinib Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Chronic Myelogenous Leukemia (CML)
1.3.3 Philadelphia Chromosome-positive?Acute Lymphoblastic Leukemia(Ph+ ALL)
1.3.4 Advanced Prostate Cancer
1.4 United States Dasatinib Market by Region
1.4.1 United States Dasatinib Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Dasatinib Status and Prospect (2012-2022)
1.4.3 Southwest Dasatinib Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Dasatinib Status and Prospect (2012-2022)
1.4.5 New England Dasatinib Status and Prospect (2012-2022)
1.4.6 The South Dasatinib Status and Prospect (2012-2022)
1.4.7 The Midwest Dasatinib Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Dasatinib (2012-2022)
1.5.1 United States Dasatinib Sales and Growth Rate (2012-2022)
1.5.2 United States Dasatinib Revenue and Growth Rate (2012-2022)

2 United States Dasatinib Market Competition by Players/Suppliers
2.1 United States Dasatinib Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Dasatinib Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Dasatinib Average Price by Players/Suppliers (2012-2017)
2.4 United States Dasatinib Market Competitive Situation and Trends
2.4.1 United States Dasatinib Market Concentration Rate
2.4.2 United States Dasatinib Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Dasatinib Manufacturing Base Distribution, Sales Area, Product Type

3 United States Dasatinib Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Dasatinib Sales and Market Share by Region (2012-2017)
3.2 United States Dasatinib Revenue and Market Share by Region (2012-2017)
3.3 United States Dasatinib Price by Region (2012-2017)

4 United States Dasatinib Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Dasatinib Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Dasatinib Revenue and Market Share by Type (2012-2017)
4.3 United States Dasatinib Price by Type (2012-2017)
4.4 United States Dasatinib Sales Growth Rate by Type (2012-2017)

5 United States Dasatinib Sales (Volume) by Application (2012-2017)
5.1 United States Dasatinib Sales and Market Share by Application (2012-2017)
5.2 United States Dasatinib Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Dasatinib Players/Suppliers Profiles and Sales Data
6.1 Bristol-Myers Squibb
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Dasatinib Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Bristol-Myers Squibb Dasatinib Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Otsuka Pharmaceutical
6.2.2 Dasatinib Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Otsuka Pharmaceutical Dasatinib Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 CTTQ PHARMA
6.3.2 Dasatinib Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 CTTQ PHARMA Dasatinib Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 APOTEX INC
6.4.2 Dasatinib Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 APOTEX INC Dasatinib Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
...

7 Dasatinib Manufacturing Cost Analysis
7.1 Dasatinib Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Dasatinib

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Dasatinib Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Dasatinib Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Dasatinib Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Dasatinib Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Dasatinib Sales Volume Forecast by Type (2017-2022)
11.3 United States Dasatinib Sales Volume Forecast by Application (2017-2022)
11.4 United States Dasatinib Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer

To Purchase this Premium Report: http://globalqyresearch.com/checkout-form/0/254520

About Us:

Global QYResearch is the one spot destination for all your research needs. Global QYResearch holds the repository of quality research reports from numerous publishers across the globe. Our inventory of research reports caters to various industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. With the complete information about the publishers and the industries they cater to for developing market research reports, we help our clients in making purchase decision by understanding their requirements and suggesting best possible collection matching their needs.

Browse Our Pharma Blog:http://pharmainvestmentnews.com/

Contact Us:

Unit1, 26 Cleveland Road, South Woodford, London, E182AN, United Kingdom

Contact: +44 20 3239 2407

Comments (0)

Add comment

Comment